» Authors » Ronald P Zweemer

Ronald P Zweemer

Explore the profile of Ronald P Zweemer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 982
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brink G, Groeneweg J, Sickinghe A, Nijman H, van Lonkhuijzen L, Lok C, et al.
J Ovarian Res . 2025 Feb; 18(1):37. PMID: 39987174
Background: As current literature does not provide sufficient data to support clear guidelines in patients with a rare adult-type granulosa cell tumor, we aim to investigate: (1) whether additional staging...
2.
Van Bommel M, Steenbeek M, IntHout J, Van Garderen T, Harmsen M, Arts-De Jong M, et al.
BJOG . 2025 Jan; PMID: 39823150
Objective: To compare menopause-related quality of life (QoL) after risk-reducing salpingectomy (RRS) versus risk-reducing salpingo-oophorectomy (RRSO) until 3 years of post-surgery. Design: A prospective study (TUBA study) with treatment allocation...
3.
Brink G, Hami N, Mertens S, Nijman H, van Lonkhuijzen L, Roes E, et al.
Mol Cancer Ther . 2024 Nov; PMID: 39600124
In patients with the rare adult-type granulosa cell tumors (aGCT), surgery is the primary treatment for both primary and recurrent disease. In cases of inoperable disease, systematic therapy is administered,...
4.
Zelisse H, van Gent M, Mom C, de Ridder S, Snijders M, Heeling M, et al.
Ann Diagn Pathol . 2024 Nov; 74:152411. PMID: 39591762
Fundamental and translational research in ovarian cancer aims to enhance understanding of disease mechanisms and improve treatment and survival outcomes. To support this, we established the Dutch multicenter, interdisciplinary Archipelago...
5.
Stroot I, Bart J, Hollema H, Wagner M, Yigit R, van Doorn H, et al.
J Natl Cancer Inst . 2024 Nov; PMID: 39579093
Background: Risk-reducing salpingo-oophorectomy (RRSO) effectively prevents high-grade serous carcinoma (HGSC) in BRCA1/2 germline pathogenic variant (GPV) carriers. Still, some women develop HGSC after RRSO without pathologic findings. This study assessed...
6.
Baeten I, Hoogendam J, Stathonikos N, Gerestein C, Jonges G, van Diest P, et al.
Cancers (Basel) . 2024 Nov; 16(21). PMID: 39518059
: Pathological ultrastaging, an essential part of sentinel lymph node (SLN) mapping, involves serial sectioning and immunohistochemical (IHC) staining in order to reliably detect clinically relevant metastases. However, ultrastaging is...
7.
Stroot I, Bart J, Hollema H, Jalving M, Wagner M, Yigit R, et al.
Gynecol Oncol . 2024 May; 187:198-203. PMID: 38795508
Objective: The aim of this study was to describe the long-term outcome of asymptomatic BRCA1/2 germline pathogenic variant (GPV) carriers with high-grade serous carcinoma (HGSC) in their risk-reducing salpingo-oophorectomy (RRSO)...
8.
Bakker M, Brink G, Poot A, Braat A, Jonges G, Zweemer R
Cancers (Basel) . 2024 Mar; 16(6). PMID: 38539473
Ovarian cancer mortality rates have not decreased significantly in the past years. As most women are still diagnosed in an advanced stage, there is a need for new treatment strategies...
9.
Olthof E, Bergink-Voorthuis B, Wenzel H, Mongula J, van der Velden J, Spijkerboer A, et al.
Insights Imaging . 2024 Feb; 15(1):36. PMID: 38332397
Objectives: Imaging is increasingly used to assess lymph node involvement in clinically early-stage cervical cancer. This retrospective study aimed to evaluate the diagnostic accuracy of MRI, CT, and [F]FDG-PET-CT. Methods:...
10.
de Jong A, Baeten I, Jansen A, Hoogendam J, Jurgenliemk-Schulz I, Zweemer R, et al.
J Minim Invasive Gynecol . 2024 Jan; 31(3):243-249.e2. PMID: 38171478
Study Objectives: Pelvic lymph node dissection (PLND) is part of the primary treatment for early-stage cervical cancer and high-intermediate risk or high-risk endometrial cancer. Pelvic lymphocele is a postoperative complication...